SEC Filings

Filing date Form Description View
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
3

Initial filing by director officer or owner of more than ten percent

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

 

 

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools